The largest database of trusted experimental protocols

X vivo medium

Manufactured by Lonza
Sourced in Switzerland, United States, Germany, Belgium

X-VIVO medium is a serum-free, chemically defined cell culture medium developed by Lonza for the growth and maintenance of a variety of cell types, including primary cells and cell lines. The medium is formulated to support cell proliferation and viability without the use of animal-derived components.

Automatically generated - may contain errors

108 protocols using x vivo medium

1

Quantifying ZIKV and HIV Infection Rates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ZIKV (Zika virus) infection rate was determined in Vero E6 cells. Therefore, 12,000 cells were seeded into 96-well plates. The next day, medium was removed and 70 µl fresh x-vivo medium (Lonza, Basel, Switzerland) and 10 µl of peptide titration series were added. Then, cells were infected with 20 µL of ZIKV MR766. Two days later, infection rates were determined with a cell-based ZIKV immunodetection assay described previously [24 (link)]. HIV infection was quantified by the reporter activity of TZMbl cells. Therefore, 10,000 cells were seeded. The next day, medium was removed and 70 µl fresh x-vivo medium (Lonza) and 10 µl of peptide titration series were added. Then, cells were infected with 20 µL of HIV-1 NL4-3. Two days later, the infection rate was determined by quantification of β-galactosidase expression according to Müller et al. [24 (link)]. All infection values were corrected for the background signal derived from uninfected cells, and untreated controls were set to 100% infection.
+ Open protocol
+ Expand
2

Sorting and Phenotyping of T-Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were thawed, and then rested overnight in x-vivo medium (Lonza, Basel, Switzerland) with 5% human serum in an incubator. The next day, cells were washed twice in FACS buffer, then stained with the following: LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit (Waltham, MA, USA), CD45RA-APC, CD62L-PE, and CD3-FITC (BD Biosciences, San José, CA, USA). Cells were stained for 30 min on ice, washed twice, and then resuspended in FACS buffer at 50 × 106 cells/mL. Next, cells were sorted on a FACS ARIA flow cytometer with appropriate application settings and compensation controls. Cell sorting was performed with a purity setting. After sorting, cells were allowed to rest in x-vivo medium (Lonza, Basel, Switzerland) in an incubator. After sorting of all the cells, samples of 104 cells were analyzed to ensure proper sorting purity. Gating strategy for the identification of CD3+ T cells for the phenotypic analysis and subsequent sorting of different memory cell fractions is provided in Supplementary Material 2. Materials and methods for intracellular cytokine staining (ICS), establishment of T-cell cultures specific for mutant CALR epitopes and statistical analyses are provided in Supplementary Material 3.
+ Open protocol
+ Expand
3

Isolation and Enrichment of Microglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 mice, at 6–8 weeks, were administered a lethal dose of Euthasol followed by transcardial perfusion with 0.9% ice cold heparinized saline. Brains were excised under aseptic conditions, and tissue dissociation was performed using the Neural Tissue Dissociation Kit, according to the manufacturer’s instructions. Following dissociation, myelin debris was separated and removed using Debris Removal Solution, according to the manufacturer’s instructions. CD11b-positive cells were enriched using anti-CD11b MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany), according to manufacturer’s instructions. The resulting cell:bead suspension was centrifuged at 400g for 10 min and resuspended in X-VIVO medium (Lonza Biosciences, Walkersville, MD), or X-VIVO medium supplemented with 1 ug/mL HMGB1 for immediate stimulation.
+ Open protocol
+ Expand
4

Generation of human macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human macrophages were generated by an adherence method utilizing monocyte-attachment medium (PromoCell, Heidelberg, DE). After an incubation for 24 h in serum-free X-Vivo medium (Lonza, Basel, CH), M-CSF (PeproTech, Rocky Hill, CA, USA) was added for macrophage generation. Human MNC were isolated from peripheral blood of healthy volunteers, as previously described (41 (link)) using Ficoll® (GE Healthcare, Chicago USA).
+ Open protocol
+ Expand
5

MHC-I Peptide Binding Assay in TAP2-deficient Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A TAP2-deficient cell line, RMAS-Dd, expressing the MHC- I H2-Dd (gift of Dr. David Raulet, U. California, Berkeley) was cultivated in serum free, X-VIVO medium (Lonza). Cell cultures were incubated with indicated peptides overnight either with or without the addition of human β2-microglobulin (hβ2m)(Sigma-Aldrich). Following culture, cells were stained with the mAb 34-5-8S (AbCam), which binds H2-Dd MHC- I molecules in a peptide-dependent, but not peptide-specific fashion (22 (link)). Stained cells were analyzed using a BD LSR II flow cytometer with FlowJo© software. The results are expressed as the fluorescence index (FI), the ratio of mean fluorescence intensity (MFI) in the presence vs absence of peptide, minus 1, as previously described (23 (link)). This method was an adaptation from previously described methods (23 (link), 24 (link)).
+ Open protocol
+ Expand
6

PBMC Stimulation with IFN-β

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two million PBMCs from six adult healthy donors (see Table 1) were cultured in X-VIVO medium (Lonza) containing 1% heat-inactivated human AB serum (Sigma-Aldrich) in the presence or absence of IFN-β (100 U/mL; Peprotech) on flat-bottom 24-well plates (BD Biosciences). Cells were harvested at 2, 6, and 18 h after stimulation and were immediately stored in TRIZOL reagent (Life Technologies) at −80°C. In addition, resting PBMCs from each donor (unstimulated; t = 0 h) also were stored in TRIZOL reagent at −80°C.
+ Open protocol
+ Expand
7

PBMC Stimulation Kinetics Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two million PBMCs from six adult healthy donors (see Table 1) were cultured in X-VIVO medium (Lonza) containing 1% heat-inactivated human AB serum (Sigma-Aldrich) in the presence or absence of IFN-β (100 U/ml; Peprotech) on flat-bottom 24-well plates (BD). Cells were harvested at 2, 6 and 18 h post-stimulation and were immediately stored in TRIZOL reagent (Life Technologies) at −80°C. In addition, resting PBMCs from each donor (unstimulated; time 0 h) were also stored in TRIZOL reagent at −80°C.
+ Open protocol
+ Expand
8

Isolation and Culture of NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood from patients with XLPDR was collected locally and shipped for analysis along with samples from control individuals. For other studies, normal NK cells were obtained from healthy donors recruited at the Department of Transfusion Medicine, NIH, with the donors’ informed consent, in accordance with the Declaration of Helsinki. Approximately 50 mL of peripheral blood was collected by venipuncture at room temperature in tubes containing sodium heparin. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood using the standard Ficoll-Paque method. NK cells were isolated from PBMCs using EasySep Human NK cell enrichment kits (STEMCELL Technologies) according to the manufacturer’s protocol. NK cells were cultured in X-vivo medium (Lonza) supplemented with 10% human serum and 100 U/mL of IL-2.
+ Open protocol
+ Expand
9

Cell Line Mycoplasma Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines used in this study were tested for mycoplasma using a PCR-based method (24 (link)). This testing was performed upon obtaining the cells and every 8–12 weeks to confirm that all experiments were performed in uninfected cells. HEK293T cells (American Type Culture Collection, ATCC) were cultured in DMEM supplemented with 10% FBS and l-glutamine. NK92mi cells were grown in X-vivo medium (Lonza) with 10% human serum. YTS cells were cultured in IMDM supplemented with 12.5% FBS. Human B lymphoblastoid 721.221 cells and ovarian carcinoma SKOV-3 cells were cultured in complete RPMI 1640 medium (Gibco, Thermo Fisher Scientific). Patient-derived dermal fibroblasts were obtained after IRB approval and informed consent, as previously described (10 (link)). Fibroblasts were cultured in DMEM supplemented with 10% FBS. Etoposide (MilliporeSigma) was used as a 1-mM solution in DMSO. Poly(dA:dT) (1 mg/mL, InvivoGen) was transfected using LyoVec (InvivoGen) following the manufacturer’s instructions.
+ Open protocol
+ Expand
10

Generating Mature Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated from healthy donor blood (Sanquin, Nijmegen, Netherlands) by density gradient centrifugation using lymphoprep (Axis-Shield). Adherent cells were obtained as previously described [32 (link)]. Immature DCs were generated by culturing the adherent cells in X-VIVO medium (Lonza) containing 2% human serum (Sanquin), with IL-4 (300 U/ml) and GM-CSF (450 U/ml; both CellGenix) for 6 days. On day 6, DCs were maturated with either a cytokine cocktail containing prostaglandin E2 (PGE2; 10 μg/ml; Pfizer), tumor necrosis factor (TNF)-α (10 ng/ml), IL-1β (5 ng/ml), and IL-6 (15 ng/ml; all CellGenix) or with toll-like receptor (TLR)3 and TLR7/8 ligands, poly[I:C] (20 μg/ml; Enzo), and R848 (4 μg/ml; InvivoGen), respectively, for 24 hours.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!